Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

SQT1665 Citations (3)

Originally described in: Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells.
Kleinstiver BP, Tsai SQ, Prew MS, Nguyen NT, Welch MM, Lopez JM, McCaw ZR, Aryee MJ, Joung JK Nat Biotechnol. 2016 Jun 27. doi: 10.1038/nbt.3620.
PubMed Journal

Articles Citing SQT1665

Articles
CRISPR-LbCpf1 prevents choroidal neovascularization in a mouse model of age-related macular degeneration. Koo T, Park SW, Jo DH, Kim D, Kim JH, Cho HY, Kim J, Kim JH, Kim JS. Nat Commun. 2018 May 10;9(1):1855. doi: 10.1038/s41467-018-04175-y. PubMed
Increasing the specificity of CRISPR systems with engineered RNA secondary structures. Kocak DD, Josephs EA, Bhandarkar V, Adkar SS, Kwon JB, Gersbach CA. Nat Biotechnol. 2019 Jun;37(6):657-666. doi: 10.1038/s41587-019-0095-1. Epub 2019 Apr 15. PubMed
CRISPR/Cas12a mediated knock-in of the Polled Celtic variant to produce a polled genotype in dairy cattle. Schuster F, Aldag P, Frenzel A, Hadeler KG, Lucas-Hahn A, Niemann H, Petersen B. Sci Rep. 2020 Aug 11;10(1):13570. doi: 10.1038/s41598-020-70531-y. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.